About the journal
Neuro-Oncology Advances is an open-access journal published by Oxford University Press in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,489 USD. Declared review time at DOAJ: 12 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Oxford University Press
- ISSN
- 2632-2498
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,489 USD
- Articles in DOAJ
- 0
- Declared review time
- 12 weeks
- Declared peer-review model
- peer_review
- Official website
- https://academic.oup.com/noa
Index listings
- DOAJ · 2020-01-20
- Indexing
- DOAJ
- APC
- 2,489 USD
- Declared review time (DOAJ)
- 12 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
0
Average review time (journal-declared via DOAJ)
12weeks
Works in OpenAlex
3700
Last recorded publication year
2026
h-index
49
i10-index
474
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2024-04-03
- Added to DOAJ
- 2020-01-20
- Declared plagiarism screening
- Not declared
- Other fees beyond APC
- No
- Declared digital preservation
- PMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 44%
- ORCID iDs in current deposits
- 43%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- NOA
- Source type
- journal
- NLM unique ID (PubMed)
- 101755003
Classification4
Subjects (DOAJ)
LCC codes
Subject areas
- Glioma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Brain Metastases and Treatment
- Brain Metastases and Treatment
- Meningioma and schwannoma management
- Meningioma and schwannoma management
- Radiomics and Machine Learning in Medical Imaging
- Radiomics and Machine Learning in Medical Imaging
Show all subjects (50)
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Neurofibromatosis and Schwannoma Cases
- Neurofibromatosis and Schwannoma Cases
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Radiopharmaceutical Chemistry and Applications
- Radiopharmaceutical Chemistry and Applications
- Neuroblastoma Research and Treatments
- Neuroblastoma Research and Treatments
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- CNS Lymphoma Diagnosis and Treatment
- CNS Lymphoma Diagnosis and Treatment
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Management of metastatic bone disease
- Management of metastatic bone disease
- Brain Tumor Detection and Classification
- Brain Tumor Detection and Classification
- Cancer Research and Treatments
- Cancer Research and Treatments
- Medical Imaging Techniques and Applications
- Medical Imaging Techniques and Applications
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- CAR-T cell therapy research
- Ferroptosis and cancer prognosis
- Nanoplatforms for cancer theranostics
- Nanoplatforms for cancer theranostics
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
- MRI in cancer diagnosis
- MRI in cancer diagnosis
- Ferroptosis and cancer prognosis
- Cancer-related cognitive impairment studies
- Cancer-related cognitive impairment studies
- Advanced Radiotherapy Techniques
- Advanced Radiotherapy Techniques
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
Keywords (DOAJ)
- neuro-oncology
- oncology
- neurology
- cancer
- central nervous system
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ